help women decide if they should take hormone therapy for menopausal symptoms

New Canadian guidelines will help women decide if they should take hormone therapy for menopausal symptoms.

About half of women on hormone therapy stopped it after the big Women's Health Initiative trial showed a higher risk of cardiovascular problems and breast cancer with Premarin or Premplus.

But despite these well-publicized results, up to 25% of these women ended up back on hormone therapy to control menopausal symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote